Discover how triptolide from Thunder God Vine inhibits ovarian cancer growth by enhancing EZH2 degradation through multiple molecular mechanisms.
Explore how STAT3 activation and hypoxic environments create a dangerous synergy that drives ovarian cancer progression and treatment resistance.
Discover how PSMC6, a proteasome subunit, plays a critical role in cisplatin-resistant ovarian cancer and opens new therapeutic possibilities.
Exploring RPN13 as a novel therapeutic target for ovarian cancer treatment, focusing on its role in the proteasome system and potential to overcome chemotherapy resistance.